Furthermore, the Sali-loaded nanoparticles decreased the expression of CD44 and CD133, and reduced the tumor seeding ability and tumor growth rate in tumor-bearing mice, compared to the free drug, suggesting the cervical CSC targeting ability of Sali. The gene discussed is PROM1; the disease is neoplasm.